NRX Pharmaceuticals, Inc. (NRXP)

2.37 +0.11 (+4.87%) USD  |  NASDAQ  |  Dec 09, 13:29
More

NRX Pharmaceuticals EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for NRXP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Synergy CHC Corp. Upgrade
Acurx Pharmaceuticals, Inc. Upgrade
IGC Pharma, Inc. Upgrade
CEL-SCI Corp. Upgrade
AIM ImmunoTech, Inc. Upgrade